CIPRO XR Drug Patent Profile
✉ Email this page to a colleague
When do Cipro Xr patents expire, and what generic alternatives are available?
Cipro Xr is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in CIPRO XR is ciprofloxacin; ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Additional details are available on the ciprofloxacin; ciprofloxacin hydrochloride profile page.
Summary for CIPRO XR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Patent Applications: | 4,455 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CIPRO XR |
| DailyMed Link: | CIPRO XR at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CIPRO XR
US Patents and Regulatory Information for CIPRO XR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | CIPRO XR | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021473-001 | Dec 13, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Bayer Hlthcare | CIPRO XR | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021473-002 | Aug 28, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CIPRO XR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | CIPRO XR | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021473-001 | Dec 13, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bayer Hlthcare | CIPRO XR | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021473-002 | Aug 28, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bayer Hlthcare | CIPRO XR | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021473-001 | Dec 13, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bayer Hlthcare | CIPRO XR | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021473-002 | Aug 28, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bayer Hlthcare | CIPRO XR | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021473-002 | Aug 28, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CIPRO XR
See the table below for patents covering CIPRO XR around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Finland | 85369 | ⤷ Try a Trial | |
| Germany | 3273892 | ⤷ Try a Trial | |
| German Democratic Republic | 202560 | VERFAHREN ZUR HERSTELLUNG VON 1-CYCLOPROPYL-6-FLUOR-1,4-DIHYDRO-4-OXO-7-PIPERAZINO CHINOLIN-3-CARBONSAEUREN | ⤷ Try a Trial |
| South Korea | 870000441 | ⤷ Try a Trial | |
| Canada | 1237431 | ACIDE 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7- CHLORO-QUINOLEINE-3-CARBOXYLIQUE; SES ESTERS ET METHODE DE PREPARATION (1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-CHLORO- QUINOLINE-3-CARBOXYLIC ACID, ESTERS AND PROCESS FOR THEIR PREPARATION) | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
